Sorry, the report is via a pay wall. It also isn't that useful because Macquarie are still on research restrictions with PLS as their adviser.
Regarding the JV debt, they do not include it in their base case.
The net cash graph provided in the report (despite having the scale make it look as inoffensive as they can) really stuck out as a warning sign to me.
Macquarie has always sugar-coated their assessment of PLS. But this is too hard to hide.
PLS chart to start 2019, page-1852
-
- There are more pages in this discussion • 557 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.07 |
Change
0.090(3.02%) |
Mkt cap ! $9.197B |
Open | High | Low | Value | Volume |
$3.05 | $3.09 | $3.02 | $74.82M | 24.46M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 750 | $3.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.07 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 750 | 3.050 |
2 | 44802 | 3.040 |
7 | 195289 | 3.030 |
12 | 445998 | 3.020 |
5 | 26550 | 3.010 |
Price($) | Vol. | No. |
---|---|---|
3.080 | 227736 | 15 |
3.090 | 254756 | 21 |
3.100 | 787128 | 86 |
3.110 | 72903 | 13 |
3.120 | 185976 | 25 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
NEWS
Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEWS
Is oil undervalued?
PLS (ASX) Chart |